UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Haematologica (Roma), 2012-03, Vol.97 (3), p.393-401

2012

Volltextzugriff (PDF)

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

Cancer research (Chicago, Ill.), 2006-06, Vol.66 (12), p.6361-6369

2006

Volltextzugriff (PDF)

SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma

Blood, 2003-04, Vol.101 (7), p.2784-2788

2003

Volltextzugriff (PDF)

A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR

Epigenetics, 2012-07, Vol.7 (7), p.772-780

2012

Volltextzugriff (PDF)

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

BMC cancer, 2008-05, Vol.8 (1), p.154-154

2008

Volltextzugriff (PDF)

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer

Breast cancer research : BCR, 2009-01, Vol.11 (3), p.R34-R34, Article R34

2009

Volltextzugriff (PDF)

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

BMC cancer, 2009-06, Vol.9 (173), p.173-173, Article 173

2009

Volltextzugriff (PDF)

Differential role of gp130-dependent STAT and Ras signalling for haematopoiesis following bone-marrow transplantation

PloS one, 2012-06, Vol.7 (6), p.e39728-e39728

2012

Volltextzugriff (PDF)

Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells

PloS one, 2011-03, Vol.6 (3), p.e18012-e18012

2011

Volltextzugriff (PDF)

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

Epigenetics, 2011-08, Vol.6 (8), p.1047-1052

2011

Volltextzugriff (PDF)

EHA Scientific Workshop Report: The Role of Epigenetics in Hematological Malignancies

Epigenetics, 2007-04, Vol.2 (2), p.71-79

2007

Volltextzugriff (PDF)

Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies

Oncogene, 2005-07, Vol.24 (30), p.4799-4805

2005

Volltextzugriff (PDF)

Beyond genetics: The emerging role of epigenetic changes in hematopoietic malignancies

International journal of hematology, 2004-08, Vol.80 (2), p.120-127

2004

Volltextzugriff (PDF)

Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

Clinical epigenetics, 2012-08, Vol.4 (1), p.12-12, Article 12

2012

Volltextzugriff (PDF)

The fundamental role of epigenetics in hematopoietic malignancies

Blood reviews, 2006, Vol.20 (1), p.1-13

2006

Volltextzugriff (PDF)

Comparative Benefit–Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach

Pain and therapy, 2022-03, Vol.11 (1), p.73-91

2022

Volltextzugriff (PDF)

DNA methylation changes in multiple myeloma

Leukemia, 2004-10, Vol.18 (10), p.1687-1692

2004

Volltextzugriff (PDF)

High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin

BMC cancer, 2014-01, Vol.14 (1), p.33-33, Article 33

2014

Volltextzugriff (PDF)

CpG island methylation patterns in chronic lymphocytic leukemia

Leukemia & lymphoma, 2009-01, Vol.50 (3), p.419-426

2009

Volltextzugriff (PDF)

Quantitative analyses of DAPK1 methylation in AML and MDS

International journal of cancer, 2012-07, Vol.131 (2), p.E138-E142

2012

Volltextzugriff (PDF)

Abstract 3142: Hypermethylation of the tissue inhibitor of metalloproteinases-2 gene in multiple myeloma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3142-3142

2012

Volltextzugriff (PDF)

Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer

Cancer research (Chicago, Ill.), 2002-10, Vol.62 (20), p.5902-5905

2002

Volltextzugriff (PDF)

Abstract 4872: Synergistic induction of cell death and apoptosis by the histone deacetylase inhibitor vorinostat and the demethylating agent 5-aza-2′-deoxycytidine in multiple myeloma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4872-4872

2010

Volltextzugriff (PDF)

Synergistic Induction of Cell Death and Apoptosis by the Histone Deacetylase Inhibitor SAHA (Vorinostat) and the Demethylating Agent DAC in Multiple Myeloma

Blood, 2009-11, Vol.114 (22), p.2393-2393

2009

Volltextzugriff (PDF)

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies

Cancer research (Chicago, Ill.), 2009-11, Vol.69 (21), p.8482-8490

2009

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(61)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Humans
(36)
Life Sciences & Biomedicine
(35)
Dna Methylation
(22)
Oncology
(20)
Middle Aged
(16)
Female
(15)
Hematology
(15)
Aged
(13)
Male
(13)
Biological And Medical Sciences
(12)
Epigenetics
(12)
Medical Sciences
(12)
Aged, 80 And Over
(11)
Adult
(9)
Cpg Islands
(9)
Hematologic And Hematopoietic Diseases
(9)
Cancer
(8)
Promoter Regions, Genetic
(8)
Gene Silencing
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms

SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma

A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

Differential role of gp130-dependent STAT and Ras signalling for haematopoiesis following bone-marrow transplantation

Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

EHA Scientific Workshop Report: The Role of Epigenetics in Hematological Malignancies

Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies

Beyond genetics: The emerging role of epigenetic changes in hematopoietic malignancies

Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

The fundamental role of epigenetics in hematopoietic malignancies

Comparative Benefit–Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach

DNA methylation changes in multiple myeloma

High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin

CpG island methylation patterns in chronic lymphocytic leukemia

Quantitative analyses of DAPK1 methylation in AML and MDS

Abstract 3142: Hypermethylation of the tissue inhibitor of metalloproteinases-2 gene in multiple myeloma

Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer

Abstract 4872: Synergistic induction of cell death and apoptosis by the histone deacetylase inhibitor vorinostat and the demethylating agent 5-aza-2′-deoxycytidine in multiple myeloma

Synergistic Induction of Cell Death and Apoptosis by the Histone Deacetylase Inhibitor SAHA (Vorinostat) and the Demethylating Agent DAC in Multiple Myeloma

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies

Suchergebnisse filtern